Brief: Precision Biosciences Strengthens Senior Leadership Team Ahead Of Anticipated Pbgene-HBV Clinical Execution
12/09/2024 12:18
Sept 12 (Reuters) - Precision BioSciences Inc DTIL.O :
* PRECISION BIOSCIENCES STRENGTHENS SENIOR LEADERSHIP TEAM
AHEAD
OF ANTICIPATED PBGENE-HBV CLINICAL EXECUTION
Source text for Eikon: ID:nBw13SHLpa
Further company coverage: DTIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing